Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists

N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists

US Patent 7217716 · Granted May 15, 2007

Estimated economic value: $75,282,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antimalarial agents2025
Antimalarial agents2025
Inhibitors of the menin-MLL interaction2025
Aurora kinase inhibitors for inhibiting mitotic progression2024
Tetracyclic heterocycle compounds useful as HIV integrase inhibitors2024
Tricyclic heterocycle compounds useful as HIV integrase inhibitors2024
Inhibitors of the menin-MLL interaction2023
Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, composi2023
Dihydropyrrolopyridine inhibitors of ROR-gamma2022
Inhibitors of the menin-MLL interaction2022
Tetracyclic heterocycle compounds useful as HIV integrase inhibitors2022
Compounds and methods for inhibiting mitotic progression2021